Author

Venkatakrishnan Harihara

RWTH Aachen University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Alessia PiergentiliiD· 1 shared Anne Kaiser· 1 shared Axel ChoidasiD· 1 shared Bert KlebliD· 1 shared Deborah ChristeniD· 1 shared Giulia RossettiiD· 1 shared Heidi E. GreulichiD· 1 shared Hubert SchorleiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessia PiergentiliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PDE3A-SLFN12 Molecular Glues Target Multiple KIT D816V Cell Types in Preclinical Models of Mast Cell Malignancies

Xuhuang Fu, Anne Kaiser, Payal Chawla, Axel Choidas, Peter Habenberger, Tiago Maié, Alessia Piergentili, Venkatakrishnan Harihara, Paul Wanek, Susanne Schmitz, Maximilian Ackermann, Deborah Christen, Jens Panse, Hubert Schorle, Michel Arock, , Martin Zenke

This paper identifies PDE3A-SLFN12 molecular glues as a novel therapeutic target for KIT D816V-driven mast cell malignancies, showing their efficacy in killing multiple KIT D816V cell types and synergy with tyrosine kinase inhibitors.

bioRxiv · Aug 18, 2026 · PreprintCancer Biology